Cargando…

Teriparatide and Abaloparatide Have a Similar Effect on Bone in Mice

Three bone anabolic pharmaceuticals are currently approved for treatment of osteoporosis, teriparatide (PTH (1–34)), the parathyroid hormone-related protein analog abaloparatide (ABL), and romosozumab. The present study compared the effect of intermittent PTH (1–34) and ABL on bone tissue directly m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brent, Mikkel Bo, Stoltenborg, Frederik Eriksen, Brüel, Annemarie, Thomsen, Jesper Skovhus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092394/ https://www.ncbi.nlm.nih.gov/pubmed/33953694 http://dx.doi.org/10.3389/fendo.2021.628994

Ejemplares similares

The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General Similar
por: Brent, Mikkel Bo, et al.
Publicado: (2020)

Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice
por: Brent, Mikkel Bo, et al.
Publicado: (2021)

Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss
por: Brent, Mikkel Bo, et al.
Publicado: (2022)

The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice
por: Brent, Mikkel Bo, et al.
Publicado: (2017)

Drill-Hole Bone Defects in Animal Models of Bone Healing: Protocol for a Systematic Review
por: Bromer, Frederik Duch, et al.
Publicado: (2022)

Animal models of disuse-induced bone loss: study protocol for a systematic review
por: Brent, Mikkel Bo, et al.
Publicado: (2020)

Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice()
por: Arlt, Heike, et al.
Publicado: (2020)

Rodent model of disuse-induced bone loss by hind limb injection with botulinum toxin A
por: Brent, Mikkel Bo, et al.
Publicado: (2020)

Artificial intelligence-assisted identification and quantification of osteoclasts
por: Emmanuel, Thomas, et al.
Publicado: (2021)

Sex-Specific Effect of High-Fat Diet on Glycerol Metabolism in Murine Adipose Tissue and Liver
por: Iena, Francesco Maria, et al.
Publicado: (2020)

Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice
por: Vegger, Jens Bay, et al.
Publicado: (2018)

Abaloparatide Exerts Bone Anabolic Effects with Less Stimulation of Bone Resorption-Related Factors: A Comparison with Teriparatide
por: Makino, Akito, et al.
Publicado: (2018)

Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide
por: Lv, Zhengtao, et al.
Publicado: (2023)

Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
por: Eastell, R., et al.
Publicado: (2019)

Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models
por: Bernhardsson, Magnus, et al.
Publicado: (2018)

Abaloparatide is an Effective Treatment Option for Postmenopausal Osteoporosis: Review of the Number Needed to Treat Compared with Teriparatide
por: Reginster, Jean-Yves, et al.
Publicado: (2018)

Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
por: Hong, Pan, et al.
Publicado: (2023)

Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling
por: Winzenrieth, R., et al.
Publicado: (2021)

Immobilization induced osteopenia is strain specific in mice
por: Lodberg, Andreas, et al.
Publicado: (2015)

Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide
por: Sahbani, Karim, et al.
Publicado: (2019)

SUN-385 Differential Effects of Abaloparatide and Teriparatide on Hip Cortical Volumetric BMD by DXA-Based 3d Modeling
por: Winzenrieth, Renaud, et al.
Publicado: (2020)

Profile of Abaloparatide and Its Potential in the Treatment of Postmenopausal Osteoporosis
por: Tella, Sri Harsha, et al.
Publicado: (2017)

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH
por: Sato, Tadatoshi, et al.
Publicado: (2021)

Organ and tissue level properties are more sensitive to age than osteocyte lacunar characteristics in rat cortical bone
por: Wittig, Nina Kølln, et al.
Publicado: (2015)

Effect of Denosumab and Teriparatide on Fracture Nonunion
por: Boutin, Regine, et al.
Publicado: (2023)

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
por: Le, Quang A., et al.
Publicado: (2018)

Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study
por: Cosman, F., et al.
Publicado: (2022)

Improvement of Skeletal Fragility by Teriparatide in Adult Osteoporosis Patients: A Novel Mechanostat-Based Hypothesis for Bone Quality
por: Sugiyama, Toshihiro, et al.
Publicado: (2015)

Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis
por: Imel, E.A., et al.
Publicado: (2020)

Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1–34)
por: Le Henaff, Carole, et al.
Publicado: (2023)

Off-Label Use of Teriparatide in Spine
por: Drakopoulos, Panagiotis, et al.
Publicado: (2021)

Phase 1b Evaluation of Abaloparatide Solid Microstructured Transdermal System (Abaloparatide-sMTS) in Postmenopausal Women with Low Bone Mineral Density
por: Miller, Paul D., et al.
Publicado: (2021)

Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With Osteoporosis
por: Dempster, David W, et al.
Publicado: (2021)

Abaloparatide and the Spine: A Narrative Review
por: Thompson, Jeremy C, et al.
Publicado: (2020)

Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report
por: Porcelli, Tommaso, et al.
Publicado: (2018)

SUN-335 Abaloparatide Prevents Unloading-Induced Bone Loss in Adult Rats
por: Teguh, Dian A, et al.
Publicado: (2020)

Effects of teriparatide on bone in autochthonous transgenic model mice for diabetes mellitus (Akita mice)
por: Ohuchi, Kentaro, et al.
Publicado: (2019)

Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia
por: Chandler, H., et al.
Publicado: (2019)

The Effect of Bone Marrow Stimulation for Cartilage Repair on the Subchondral Bone Plate
por: Elmholt, Simone Birkebæk, et al.
Publicado: (2022)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
por: Hirooka, Yasuaki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0n68n1hk4g1bv84vju4pcg5v3a